Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Aptinyx Inc. (APTX)

0.6999   0.1 (16.65%) 05-16 02:13
Open: 0.601 Pre. Close: 0.6
High: 0.704 Low: 0.601
Volume: 136,370 Market Cap: 47(M)
Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic peripheral neuropathy, as well as in Phase II/b clinical trial for treating fibromyalgia. It is also developing NYX-783, an N-methyl-D-aspartate receptors (NMDAr) modulator that is in Phase II/b clinical trial to treat post-traumatic stress disorder; and NYX-458, an NMDAr modulator, which is in Phase II clinical study for the treatment of Parkinson's disease cognitive impairment. The company has a research collaboration agreement with Allergan plc. Aptinyx Inc. was incorporated in 2015 and is headquartered in Evanston, Illinois.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.71 - 0.71 0.71 - 0.71
Low: 0.59 - 0.6 0.6 - 0.6
Close: 0.69 - 0.7 0.7 - 0.71

Technical analysis

as of: 2022-05-13 4:36:21 PM
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 1.27     One year: 1.65
Support: Support1: 0.57    Support2: 0.47
Resistance: Resistance1: 1.09    Resistance2: 1.41
Pivot: 0.83
Moving Average: MA(5): 0.64     MA(20): 0.87
MA(100): 2.41     MA(250): 2.49
MACD: MACD(12,26): -0.4     Signal(9): -0.4
Stochastic oscillator: %K(14,3): 11.3     %D(3): 5.6
RSI: RSI(14): 29.2
52-week: High: 4.73  Low: 0.57
Average Vol(K): 3-Month: 427 (K)  10-Days: 240 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ APTX ] has closed above bottom band by 27.1%. Bollinger Bands are 35% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Sun, 15 May 2022
Tronsmart Launches Onyx Ace Pro TWS Earbuds With Qualcomm® aptX™ Adaptive Audio Decoding - PR Newswire APAC - PR Newswire Asia

Sat, 14 May 2022
Aptinyx (NASDAQ:APTX) Releases Earnings Results, Beats Expectations By $0.02 EPS - Defense World

Fri, 13 May 2022
Aptinyx Inc. (APTX) Q1 2022 Earnings Call Transcript - The Motley Fool

Mon, 09 May 2022
Jabra Elite 4 Active review: Ideal workout buds on a budget - Android Police

Thu, 05 May 2022
Aptinyx (APTX) Set to Announce Quarterly Earnings on Thursday - Defense World

Wed, 04 May 2022
Sennheiser Sport TWS earbuds launched in India with aptX audio and quad-mic setup - Digit

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 0 (M)
Shares Float 68 (M)
% Held by Insiders 4.496e+007 (%)
% Held by Institutions 3.4 (%)
Shares Short 1,480 (K)
Shares Short P.Month 0 (K)

Stock Financials

EPS -7.401e+007
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin (%) 0
Operating Margin (%) -7
Return on Assets (ttm) 453.3
Return on Equity (ttm) -35.1
Qtrly Rev. Growth 1e+006
Gross Profit (p.s.) 0
Sales Per Share -57.1
EBITDA (p.s.) -4.9945e+007
Qtrly Earnings Growth -1.2
Operating Cash Flow 0 (M)
Levered Free Cash Flow -63 (M)

Stock Valuations

PE Ratio -0.01
PEG Ratio 0
Price to Book value 0
Price to Sales -0.02
Price to Cash Flow 0.54

Stock Dividends

Dividend 0
Forward Dividend 1.58e+006
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.